Hofseth BioCare ASA (OSL:HBC)
1.100
+0.015 (1.38%)
Nov 4, 2026, 12:02 PM CET
Hofseth BioCare ASA Ratios and Metrics
Market cap in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 574 | 567 | 586 | 543 | 728 | 736 | 1,011 | 699 | 709 | 839 | 822 | 1,035 | 1,118 | 1,047 | 1,019 | 1,300 | 1,264 | 1,360 | 1,753 | 2,469 | 2,326 | |
Market Cap Growth (YoY) | -26.06% | -22.91% | -42.07% | -22.35% | 2.61% | -12.26% | 23.06% | -32.49% | -36.58% | -19.90% | -19.38% | -20.36% | -11.56% | -23.00% | -41.87% | -47.36% | -45.64% | -52.50% | -46.62% | -29.59% | -20.32% |
Enterprise Value | 804 | 890 | 878 | 757 | 937 | 899 | 1,156 | 870 | 861 | 978 | 934 | 1,116 | 1,202 | 1,124 | 1,090 | 1,359 | 1,418 | 1,464 | 1,842 | 2,523 | 2,341 |
Last Close Price | 1.10 | 1.38 | 1.43 | 1.32 | 1.77 | 1.79 | 2.46 | 1.70 | 1.73 | 2.04 | 2.08 | 2.62 | 2.83 | 2.65 | 2.58 | 3.29 | 3.20 | 3.80 | 4.90 | 6.90 | 6.50 |
Price Ratios
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
PE Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | -9.94 | - | - | - | - | - | - | - |
Forward PE | - | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 | 1.52 |
PS Ratio | 2.37 | 2.34 | 2.39 | 2.12 | 2.92 | 2.81 | 3.69 | 2.63 | 2.86 | 3.65 | 3.64 | 4.74 | 5.46 | 5.66 | 7.58 | 10.79 | 11.20 | 14.11 | 17.26 | 28.18 | 27.50 |
PB Ratio | - | -18.06 | -5.25 | -7.18 | -26.13 | 2250.26 | 38.53 | 11.77 | 6.88 | 6.10 | 5.28 | 25.16 | 11.89 | 8.97 | 9.05 | 8.78 | 6.80 | 17.46 | 16.23 | 17.59 | 13.20 |
P/TBV Ratio | - | - | - | - | - | - | 44.78 | 12.47 | 7.15 | 6.28 | 5.43 | 28.44 | 12.48 | 9.34 | 9.47 | 9.14 | 9.86 | 56.40 | 31.33 | 28.06 | 18.35 |
P/FCF Ratio | - | - | - | -11.28 | - | - | - | -50.48 | - | -31.77 | - | - | 20.33 | 136.63 | - | -26.42 | - | - | - | - | - |
P/OCF Ratio | 288.96 | - | - | -19.12 | -30.86 | - | - | -61.30 | - | -43.60 | - | - | 17.39 | 99.43 | -28.11 | -28.78 | - | - | - | - | - |
EV Ratios
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
EV/Sales Ratio | 3.32 | 3.67 | 3.58 | 2.95 | 3.76 | 3.43 | 4.22 | 3.28 | 3.47 | 4.25 | 4.13 | 5.11 | 5.87 | 6.08 | 8.11 | 11.29 | 12.55 | 15.20 | 18.14 | 28.80 | 27.68 |
EV/EBITDA Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | -16.47 | - | - | - | - | - | - | - |
EV/EBIT Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | -11.68 | - | - | - | - | - | - | - |
EV/FCF Ratio | - | - | - | -15.73 | - | - | - | -62.87 | - | -37.07 | - | - | 21.85 | 146.74 | - | -27.64 | - | - | - | - | - |
Financial Efficiency
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Debt / Equity Ratio | -10.78 | -10.78 | -3.34 | -4.76 | -10.06 | 849.47 | 9.00 | 2.88 | 1.90 | 1.29 | 1.04 | 6.83 | 1.06 | 0.87 | 0.90 | 0.70 | 0.57 | 2.05 | 1.25 | 0.99 | 0.80 |
Debt / EBITDA Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.38 | - | - | - | - | - | - | - |
Debt / FCF Ratio | - | - | - | -7.48 | - | - | - | -12.34 | - | -6.73 | - | - | 1.81 | 13.22 | - | -2.12 | - | - | - | - | - |
Net Debt / Equity Ratio | -7.34 | -7.34 | -2.90 | -3.88 | -7.71 | 641.40 | 6.26 | 2.45 | 1.67 | 1.11 | 0.90 | 6.25 | 0.87 | 0.73 | 0.69 | 0.49 | 0.32 | 1.98 | 0.97 | 0.64 | 0.31 |
Net Debt / EBITDA Ratio | -2.34 | -2.39 | -3.47 | -3.53 | -2.64 | -2.78 | -2.28 | -2.04 | -2.00 | -1.88 | -2.31 | -3.51 | -1.39 | -1.24 | -0.74 | -0.70 | -0.61 | -1.50 | -1.06 | -0.97 | -0.61 |
Net Debt / FCF Ratio | -8.59 | -8.40 | -5.64 | -6.09 | -6.40 | -4.78 | -20.24 | -10.50 | -3.69 | -5.77 | -5.61 | -47.28 | 1.49 | 11.04 | -2.04 | -1.46 | -0.51 | -1.55 | -1.48 | -1.05 | -0.62 |
Asset Turnover | 0.60 | 0.60 | 0.65 | 0.70 | 0.66 | 0.68 | 0.71 | 0.73 | 0.65 | 0.58 | 0.58 | 0.55 | 0.50 | 0.47 | 0.34 | 0.29 | 0.26 | 0.23 | 0.24 | 0.20 | 0.23 |
Inventory Turnover | 2.77 | 2.41 | 1.95 | 4.14 | 2.01 | 2.35 | 2.71 | 4.42 | 2.89 | 2.44 | 1.32 | 2.77 | 1.24 | 0.99 | 1.47 | 1.36 | 0.93 | 0.73 | 0.96 | 1.49 | 0.62 |
Quick Ratio | 0.57 | 0.57 | 0.26 | 0.39 | 0.40 | 0.52 | 0.50 | 0.30 | 0.30 | 0.34 | 0.33 | 0.17 | 0.15 | 0.17 | 0.20 | 0.31 | 0.42 | 0.15 | 0.29 | 0.49 | 0.70 |
Current Ratio | 0.85 | 0.85 | 0.52 | 0.67 | 0.81 | 0.97 | 0.84 | 0.67 | 0.73 | 0.87 | 0.99 | 0.52 | 0.67 | 0.77 | 0.84 | 1.02 | 1.28 | 0.90 | 0.92 | 1.13 | 1.43 |
Return on Equity (ROE) | - | - | - | - | -346.49% | -198.77% | -142.28% | -249.37% | -135.42% | -95.34% | -72.94% | -112.79% | -66.44% | -108.36% | -126.49% | -95.28% | -75.30% | -95.30% | -78.26% | -62.58% | -95.62% |
Return on Assets (ROA) | -17.57% | -17.57% | -19.85% | -19.13% | -18.45% | -18.06% | -17.03% | -18.00% | -19.16% | -17.61% | -14.75% | -16.00% | -13.41% | -15.23% | -20.82% | -19.41% | -18.41% | -19.57% | -18.87% | -16.94% | -19.23% |
Return on Capital Employed (ROCE) | -61.60% | -61.60% | -107.90% | -71.40% | -62.40% | -52.60% | -55.80% | -61.50% | -61.00% | -48.80% | -36.80% | -74.20% | -48.50% | -46.60% | -65.20% | -53.80% | -45.70% | -58.70% | -55.50% | -44.70% | -37.10% |
Yields
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Earnings Yield | -31.38% | -24.07% | -23.61% | -24.86% | -17.91% | -18.62% | -12.80% | -17.93% | -18.82% | -14.45% | -11.91% | -10.31% | -8.32% | -10.06% | -13.69% | -10.57% | -10.78% | -10.22% | -7.72% | -5.12% | -5.17% |
FCF Yield | -4.68% | -4.84% | -9.79% | -8.87% | -4.61% | -5.96% | -0.80% | -1.98% | -6.59% | -3.15% | -3.05% | -0.53% | 4.92% | 0.73% | -3.76% | -3.78% | -9.35% | -7.30% | -4.03% | -3.43% | -3.76% |
Buyback Yield / Dilution | - | -3.40% | -3.40% | 0.24% | -0.24% | 0.04% | -0.13% | -3.99% | -3.74% | -4.04% | -3.86% | -0.04% | -0.75% | -9.05% | -9.05% | -10.69% | -9.92% | - | -1.54% | -1.30% | -6.88% |